Iranian Journal of Basic Medical Sciences

Iranian Journal of Basic Medical Sciences

A systematic review of the neuroprotective effects of conditioned media in preclinical models of neurological disorders

Document Type : Review Article

Authors
1 Medical Toxicology Research Center, Mashhad University of Medical Sciences, Mashhad, Iran
2 Targeted Drug Delivery Research Center, Pharmaceutical Technology Institute, Mashhad University of Medical Sciences, Mashhad, Iran
3 Department of Pharmacodynamics and Toxicology, School of Pharmacy, Mashhad University of Medical Sciences, Mashhad, Iran
10.22038/ijbms.2026.92362.19976
Abstract
Conditioned media (CM) derived from cultured cells, particularly mesenchymal stem cells (MSCs), astrocytes, and glial cells, contain bioactive factors including growth factors, cytokines, and extracellular vesicles (EVs) that exert paracrine neuroprotective effects in preclinical models of neurological disorders.This systematic review, conducted in accordance with PRISMA guidelines and encompassing studies published in PubMed, Scopus, and Web of Science from January 2010 to January 2026, synthesizes evidence on the neuroprotective efficacy of CM in preclinical models of Alzheimer’s disease, Parkinson’s disease, ischemic stroke, traumatic brain injury, Huntington’s disease, amyotrophic lateral sclerosis, spinal cord injury, multiple sclerosis, and retinal disorders. Across 58 included studies, CM consistently demonstrated robust neuroprotective effects through multiple mechanisms: reduction of neuroinflammation (e.g., microglial polarization toward anti-inflammatory phenotypes and down-regulation of pro-inflammatory cytokines), inhibition of apoptosis and oxidative stress, promotion of neuronal survival and synaptic plasticity, and enhancement of regenerative processes such as neurogenesis, angiogenesis, and axonal repair. These benefits were mediated primarily by secreted trophic factors (e.g., BDNF, GDNF, VEGF, IGF-2) and EVs, with preconditioning strategies further enriching the secretome for greater potency. Preclinical evidence strongly supports CM as a promising cell-free therapeutic approach with multifactorial neuroprotective mechanisms and advantages over cell-based therapies, including reduced risks of immune rejection and tumorigenicity. Standardization of CM preparation, detailed characterization of bioactive components, and progression to clinical trials are essential to realize its translational potential for neurological disorders. Limitations include the lack of protocol registration and a meta-analysis.
Keywords
Subjects

1.    GBD 2021 Nervous System Disorders Collaborators. Global, regional, and national burden of disorders affecting the nervous system, 1990–2021: A systematic analysis for the Global Burden of Disease Study 2021. Lancet Neurol 2024;23:344-381.
2.    Wells RE, Baute V, Wahbeh H. Complementary and integrative medicine for neurologic conditions. Med Clin North Am 2017;101:881-893.
3.    Hosseini M, Alidoust L, Akhoondian M, Atefi AH, Keivanlou MH, Hedayati Ch M, et al. Stem cell-conditioned medium is a promising treatment for Alzheimer’s disease. Behav Brain Res 2023;452:114543.
4.    Widowati W, Onggowidjaja P, Vosough M, Triharsiwi DN, Distya AP, Nurani LW, Rahmawati I, Aryani A, Priyandoko D, Azis R, Hadiprasetyo DS, Rajendran P., Abass KS, Rifana SD. Hepatoprotective effect of hUC-MSC secretome in LPS-induced HepG2 cells. Iran J Basic Med Sci 2026;29:901-908. 
5.    Rostami H, Haramshahi SMA, Vousooghi N, Shamlou S, Shahmahmoudi Z, Milan P. Brouki, Verdi J. Enhanced effects of Wharton’s jelly–derived MSC secretome and microbial exopolysaccharide on cellular responses and tissue repair in diabetic wound healing. Iran J Basic Med Sci 2026;e28293. 
6.    Nasiri N, Hemmati P, Tabaie SM. Conditioned medium from mesenchymal stem cells: Towards skin tissue engineering and wound healing. Iran J Basic Med Sci 2026;29:181-190.
7.     Tolstova T, Dotsenko E, Luzgina N, Rusanov A. Preconditioning of mesenchymal stem cells enhances the neuroprotective effects of their conditioned medium in an Alzheimer’s disease in vitro model. Biomedicines 2024;12:2243.
8.    Leonov G, Salikhova D, Shedenkova M, Bukharova T, Fatkhudinov T, Goldshtein D. Comparative study of the protective and neurotrophic effects of neuronal and glial progenitor cells-derived conditioned media in a model of glutamate toxicity in vitro. Biomolecules 2023;13:1784.
9.    Liang P, Liu J, Xiong J, Liu Q, Zhao J, Liang H, et al. Neural stem cell-conditioned medium protects neurons and promotes propriospinal neurons relay neural circuit reconnection after spinal cord injury. Cell Transplant 2014;23 Suppl 1:S45-S56.
10.    Huang TY, Naruphontjirakul P, Tseng SC, Su WT. Protective effect of conditioned medium derived from melatonin-stimulated stem cells from the apical papilla on glutamate-induced neurotoxicity in PC12 cells. Neuroscience 2025;570:72-83.
11.    Lim HC, Lee ST, Chu K, Joo KM, Kang L, Im WS, et al. Neuroprotective effect of neural stem cell-conditioned media in in vitro model of Huntington’s disease. Neurosci Lett 2008;435:175-180. 
12.    Aghaei Z, Karbalaei N, Namavar MR, Haghani M, Razmkhah M, Ghaffari MK, et al. Neuroprotective effect of wharton’s jelly-derived mesenchymal stem cell-conditioned medium (WJMSC-CM) on diabetes-associated cognitive impairment by improving oxidative stress, neuroinflammation, and apoptosis. Stem Cells Int 2023;2023:7852394.
13.    Rajan TS, Diomede F, Bramanti P, Trubiani O, Mazzon E. Conditioned medium from human gingival mesenchymal stem cells protects motor-neuron-like NSC-34 cells against scratch-injury-induced cell death. Int J Immunopathol Pharmacol 2017;30:383-394. 
14.    Egashira Y, Sugitani S, Suzuki Y, Mishiro K, Tsuchiya T, Noguchi H, et al. The conditioned medium of murine and human adipose-derived stem cells exerts neuroprotective effects against experimental stroke model. Brain Res 2012;1461:87-95.
15.    Szekiova E, Slovinska L, Blasko J, Plsikova J, Cizkova D. The neuroprotective effect of rat adipose tissue-derived mesenchymal stem cell-conditioned medium on cortical neurons using an in vitro model of SCI inflammation. Neurol Res 2018;40:258-267.
16.    Doeppner TR, Traut V, Heidenreich A, Kaltwasser B, Bosche B, Bähr M, et al. Conditioned medium derived from neural progenitor cells induces long-term post-ischemic neuroprotection, sustained neurological recovery, neurogenesis, and angiogenesis. Mol Neurobiol 2017;54:1531-1540.
17.    Zangiabadi I, Ilaghi M, Shamsara A, Eftekhar-Vaghefi SH, Saheli M, Shabani M. Exploring the impact of acetylsalicylic acid and conditioned medium obtained from mesenchymal cells, individually and in combination, on cognitive function, histological changes, and oxidant-antioxidant balance in male rats with hippocampal injury. Brain Behav 2024;14:e70010. 
18.    Yang H, Wang C, Chen H, Li L, Ma S, Wang H, et al. Neural stem cell-conditioned medium ameliorated cerebral ischemia-reperfusion injury in rats. stem Cells Int 2018;2018:4659159. 
19.    Rajan TS, Giacoppo S, Trubiani O, Diomede F, Piattelli A, Bramanti P, et al. Conditioned medium of periodontal ligament mesenchymal stem cells exert anti-inflammatory effects in lipopolysaccharide-activated mouse motoneurons. Exp Cell Res 2016;349:152-161. 
20.    Baez-Jurado E, Vega GG, Aliev G, Tarasov VV, Esquinas P, Echeverria V, et al. Blockade of neuroglobin reduces protection of conditioned medium from human mesenchymal stem cells in human astrocyte model (T98G) under a scratch assay. Mol Neurobiol 2018 Mar;55:2285-2300. 
21.    Wang T, Fang X, Yin ZS. Endothelial progenitor cell-conditioned medium promotes angiogenesis and is neuroprotective after spinal cord injury. Neural Regen Res 2018;13:887-895.  
22.    Jha KA, Gentry J, Del Mar NA, Reiner A, Sohl N, Gangaraju R. Adipose tissue-derived mesenchymal stem cell concentrated conditioned medium alters the expression pattern of glutamate regulatory proteins and aquaporin-4 in the retina after mild traumatic brain injury. J Neurotrauma 2021;38:1702-1716. 
23.    Hui X, Wang M, Zhang L, Liu J, Wang M, Hu W, et al. Conditioned media of choroid plexus epithelium cells attenuates high pi-induced calcification of MOVAS cells by inhibiting ROS-mediated signal pathways. Front Physiol 2021;12:607739.
24.    Ahmadi F, Salmasi Z, Mojarad M, Eslahi A, Tayarani-Najaran Z. G-CSF augments the neuroprotective effect of conditioned medium of dental pulp stem cells against hypoxic neural injury in SH-SY5Y cells. Iran J Basic Med Sci 2021;24:1743-1752. 
25.    Jia G, Yang H, Diao Z, Liu Y, Sun C. Neural stem cell conditioned medium alleviates Aβ25-35 damage to SH-SY5Y cells through the PCMT1/MST1 pathway. Eur J Histochem 2020;64:3135.
26.    Nikkhah E, Kalalinia F, Asgharian Rezaee M, Tayarani-Najaran Z. Suppressive effects of dental pulp stem cells and its conditioned medium on development and migration of colorectal cancer cells through MAPKinase pathways. Iran J Basic Med Sci 2021; 24:1292-1300. 
27.    Diniz LP, Tortelli V, Matias I, Morgado J, Bérgamo Araujo AP, Melo HM, et al. Astrocyte transforming growth factor beta 1 protects synapses against Aβ oligomers in Alzheimer’s disease model. J Neurosci. 2017;37:6797-6809.
28.    Mita T, Furukawa-Hibi Y, Takeuchi H, Hattori K, Yamada K, Hibi H, et al. Conditioned medium from the stem cells of human dental pulp improves cognitive function in a mouse model of Alzheimer’s disease. Brain Res 2015;1624:402-412.
29.    Mehrabadi S, Motevaseli E, Sadr SS, Moradbeygi K. Hypoxic-conditioned medium from adipose tissue mesenchymal stem cells improved neuroinflammation through alteration of toll-like receptor (TLR) 2 and TLR4 expression in a model of Alzheimer’s disease rats. Behav Brain Res 2020;379:112362.
30.    Wihadmadyatami H, Zulfikar MA, Herawati H, Karnati S, Saragih GR, Aliffia D, et al. Neuroprotection effect of bovine umbilical mesenchymal stem cell-conditioned medium on the rat model of Alzheimer’s disease mediated by up-regulation of BDNF and NGF and down-regulation of TNF-α and IL-1β. Open Vet J 2025;15:151-161. 
31.    Chierchia A, Chirico N, Boeri L, Raimondi I, Riva GA, Raimondi MT, et al. Secretome released from hydrogel-embedded adipose mesenchymal stem cells protects against the Parkinson’s disease related toxin 6-hydroxydopamine. Eur J Pharm Biopharm 2017;121:113-120.
32.    Cheng XY, Biswas S, Li J, Mao CJ, Chechneva O, Chen J, et al. Human iPSCs derived astrocytes rescue rotenone-induced mitochondrial dysfunction and dopaminergic neurodegeneration in vitro by donating functional mitochondria. Transl Neurodegener 2020;9:13.
33.    Ramalingam M, Jang S, Hwang J, Cho HH, Kim BC, Jeong HS. Neural-induced human adipose tissue-derived stem cell secretome exerts neuroprotection against rotenone-induced Parkinson’s disease in rats. Stem Cell Res Ther 2025;16:24.
34.    Di Santo S, Seiler S, Ducray AD, Widmer HR. Conditioned medium from endothelial progenitor cells promotes number of dopaminergic neurons and exerts neuroprotection in cultured ventral mesencephalic neuronal progenitor cells. Brain Res 2019; 1720:146330. 
35.    Nakhaeifard M, Haji Ghasem Kashani M, Goudarzi I, Rezaei A. Conditioned medium protects dopaminergic neurons in parkinsonian rats. Cell J 2018;20:348-354. 
36.    Li H, Yahaya BH, Ng WH, Yusoff NM, Lin J. Conditioned medium of human menstrual blood-derived endometrial stem cells protects against MPP+-induced cytotoxicity in vitro. Front Mol Neurosci 2019;12:80. 
37.    Zhang HY, Jiang YC, Li JR, Yan JN, Wang XJ, Shen JB, Ke KF, Gu XS. Neuroprotective effects of insulin-like growth factor-2 in 6-hydroxydopamine-induced cellular and mouse models of Parkinson’s disease. Neural Regen Res 2023;18:1099-1106. 
38.    Zhang X, Wang Y, Lv J. STAT4 targets KISS1 to inhibit the oxidative damage, inflammation and neuronal apoptosis in experimental PD models by inactivating the MAPK pathway. Neurochem Int 2024;175:105683. 
39.    Ramalingam M, Jeong HS, Hwang J, Cho HH, Kim BC, Kim E, et al. Autophagy signaling by neural-induced human adipose tissue-derived stem cell-conditioned medium during rotenone-induced toxicity in SH-SY5Y cells. Int J Mol Sci 2022;23:4193. 
40.    Chen YR, Lai PL, Chien Y, Lee PH, Lai YH, Ma HI, et al. Improvement of impaired motor functions by human dental exfoliated deciduous teeth stem cell-derived factors in a rat model of Parkinson’s disease. Int J Mol Sci 2020;21:3807. 
41.    Sharma S, Yang B, Strong R, Xi X, Brenneman M, Grotta JC, et al. Bone marrow mononuclear cells protect neurons and modulate microglia in cell culture models of ischemic stroke. J Neurosci Res 2010;88:2869-2876.
42.    Shindo A, Maki T, Mandeville ET, Liang AC, Egawa N, Itoh K, Itoh N, et al. Astrocyte-derived pentraxin 3 supports blood-brain barrier integrity under acute phase of stroke. Stroke 2016;47:1094-10100. 
43.    Hur HJ, Lee JY, Kim DH, Cho MS, Lee S, Kim HS, et al. Conditioned medium of human pluripotent stem cell-derived neural precursor cells exerts neurorestorative effects against ischemic stroke model. Int J Mol Sci 2022;23:7787. 
44.    Cunningham CJ, Wong R, Barrington J, Tamburrano S, Pinteaux E, Allan SM. Systemic conditioned medium treatment from interleukin-1 primed mesenchymal stem cells promotes recovery after stroke. Stem Cell Res Ther 2020;11:32. 
45.    Shooshtari MK, Moradi Vastegani S, Farbood Y, Sarkaki A, Bayati V, Nejaddehbashi F, et al. Neuroprotective potential of conditioned medium from adipose and liver mesenchymal stem cells in a rat model of global cerebral ischemia-reperfusion injury. Curr Mol Med 2026;26:592-605.
46.    Scheibe F, Klein O, Klose J, Priller J. Mesenchymal stromal cells rescue cortical neurons from apoptotic cell death in an in vitro model of cerebral ischemia. Cell Mol Neurobiol 2012;32:567-576. 
47.    Jameie F, Dianatpour M, Dara M, Jamali Z, Ghorbani N, Ünal G, et al. Hair follicle stem cell-derived secretome protects astrocytes in an in vitro ischemia/reperfusion model. Anat Cell Biol 2025;58:264-273. 
48.    Faezi M, Nasseri Maleki S, Aboutaleb N, Nikougoftar M. The membrane mesenchymal stem cell derived conditioned medium exerts neuroprotection against focal cerebral ischemia by targeting apoptosis. J Chem Neuroanat 2018;94:21-31. 
49.    Aboutaleb N, Faezi M, Nasseri Maleki S, Nazarinia D, Razavi Tousi SMT, Hashemirad N. Conditioned medium obtained from mesenchymal stem cells attenuates focal cerebral ischemia reperfusion injury through activation of ERK1/ERK2-BDNF signaling pathway. J Chem Neuroanat 2019;97:87-98. 
50.    Singh A, Chen R. Astrocyte-conditioned medium induces protection against ischaemic injury in primary rat neurons. Neuroglia 2025;6:27.
51.    Jiang RH, Wu CJ, Xu XQ, Lu SS, Zu QQ, Zhao LB, et al. Hypoxic conditioned medium derived from bone marrow mesenchymal stromal cells protects against ischemic stroke in rats. J Cell Physiol 2019;234:1354-1368. 
52.    Cho YJ, Song HS, Bhang S, Lee S, Kang BG, Lee JC, et al. Therapeutic effects of human adipose stem cell-conditioned medium on stroke. J Neurosci Res 2012;90:1794-802. 
53.    Amini A, Shekari F, Assar Kashani S, Eslami N, Nazari A, Tofigh N, et al. Clonal mesenchymal stem cell-derived extracellular vesicles improve mouse model of weight drop-induced traumatic brain injury through reducing cistauosis and apoptosis. Exp Neurol 2023;367:114467. 
54.    Pischiutta F, Tribuzio F, Magatti M, De Simone G, Moro F, Nattino G, et al. Mesenchymal stromal cell secretome and its key bioactive metabolites induce long-term neuroprotection after traumatic brain injury in mice. Adv Sci (Weinh) 2025;12:e15508. 
55.    Nakashima M, Gotoh M, Hashimoto K, Endo M, Murakami-Murofushi K, Ikeshima-Kataoka H, et al. The neuroprotective function of 2-carba-cyclic phosphatidic acid: Implications for tenascin-C via astrocytes in traumatic brain injury. J Neuroimmunol 2021;361:577749. 
56.    Liu XYE, Park E, Barretto T, Liu E, Ferrier GA, Tavakkoli J, J Baker A. Effect of Human Umbilical Cord Perivascular Cell-Conditioned Media in an Adult Zebrafish Model of Traumatic Brain Injury.  Zebrafish. 2020;17:177-186. 
57.    Di Pardo A, Ciaglia E, Cattaneo M, Maciag A, Montella F, Lopardo V, et al. The longevity-associated variant of BPIFB4 improves a CXCR4-mediated striatum-microglia crosstalk preventing disease progression in a mouse model of Huntington’s disease. Cell Death Dis 2020;11:546. 
58.    Ruiz C, Casarejos MJ, Gomez A, Solano R, de Yebenes JG, Mena MA. Protection by glia-conditioned medium in a cell model of Huntington disease. PLoS Curr 2012;4:e4fbca54a2028b. 
59.    Perucho J, Casarejos MJ, Gómez A, Ruíz C, Fernández-Estevez MÁ, Muñoz MP, et al. Striatal infusion of glial conditioned medium diminishes huntingtin pathology in r6/1 mice. PLoS One 2013;8:e73120. 
60.    Masegosa VM, Fritz E, Corvalan D, Rojas F, Garcés P, Navarro X, et al. Novel dual mechanism GRT-X agonist acting on Kv7 potassium channel/translocator protein receptor prevents motoneuron degeneration following exposure to mouse and human amyotrophic lateral sclerosis/frontotemporal dementia astrocyte-conditioned media. ACS Chem Neurosci 2025;16:2887-2900. 
61.    Tang J, Kang Y, Zhou Y, Chen Q, Lan J, Liu X, et al. Umbilical cord mesenchymal stem cell-conditioned medium inhibits microglial activation to ameliorate neuroinflammation in amyotrophic lateral sclerosis mice and cell models. Brain Res Bull 2023;202:110760. 
62.    Kim D, Kim S, Sung A, Patel N, Wong N, Conboy MJ, et al. Autologous treatment for ALS with implication for broad neuroprotection. Transl Neurodegener 2022;11:16. 
63.    Sun H, Bénardais K, Stanslowsky N, Thau-Habermann N, Hensel N, Huang D, et al. Therapeutic potential of mesenchymal stromal cells and MSC conditioned medium in amyotrophic lateral sclerosis (ALS)--in vitro evidence from primary motor neuron cultures, NSC-34 cells, astrocytes and microglia. PLoS One 2013;8:e72926. 
64.    Lan J, Zhou Y, Wang H, Tang J, Kang Y, Wang P, et al. Protective effect of human umbilical cord mesenchymal stem cell derived conditioned medium in a mutant TDP-43 induced motoneuron-like cellular model of ALS. Brain Res Bull 2023;193:106-116.
65.    Ueda T, Ito T, Inden M, Kurita H, Yamamoto A, Hozumi I. Stem cells from human exfoliated deciduous teeth-conditioned medium (SHED-CM) is a promising treatment for amyotrophic lateral sclerosis. Front Pharmacol 2022;13:805379.
66.    Yang Z, Liang Z, Rao J, Xie H, Zhou M, Xu X, et al. Hypoxic-preconditioned mesenchymal stem cell-derived small extracellular vesicles promote the recovery of spinal cord injury by affecting the phenotype of astrocytes through the miR-21/JAK2/STAT3 pathway. CNS Neurosci Ther 2024;30:e14428. 
67.    Cheng Z, Bosco DB, Sun L, Chen X, Xu Y, Tai W, et al. Neural stem cell-conditioned medium suppresses inflammation and promotes spinal cord injury recovery. Cell Transplant 2017;26:469-482. 
68.    Wood CR, Juárez EH, Ferrini F, Myint P, Innes J, Lossi L, et al. Mesenchymal stem cell conditioned medium increases glial reactivity and decreases neuronal survival in spinal cord slice cultures. Biochem Biophys Rep 2021;26:100976. 
69.    Juárez EH, Wood CR, Davies R, Kehoe O, Johnson WEB, Merighi A, et al. ST2-conditioned medium fosters dorsal horn cell excitability and synaptic transmission in cultured mouse spinal cord. Stem Cell Rev Rep 2023;19:2918-2928. 
70.    Chen YT, Tsai MJ, Hsieh N, Lo MJ, Lee MJ, Cheng H, et al. The superiority of conditioned medium derived from rapidly expanded mesenchymal stem cells for neural repair. Stem Cell Res Ther. 2019;10:390.
71.    Yeng CH, Chen PJ, Chang HK, Lo WY, Wu CC, Chang CY, et al. Attenuating spinal cord injury by conditioned medium from human umbilical cord blood-derived CD34+ cells in rats. Taiwan J Obstet Gynecol 2016;55:85-93.
72.    Yousefi F, Ebtekar M, Soleimani M, Soudi S, Hashemi SM. In vivo immunomodulatory effects of adipose-derived mesenchymal stem cells conditioned medium in experimental autoimmune encephalomyelitis. Immunol Lett 2016;172:94-105.
73.    Safaeinejad F, Asadi S, Ghafghazi S, Niknejad H. The synergistic anti-apoptosis effects of amniotic epithelial stem cell conditioned medium and ponesimod on the oligodendrocyte cells. Front Pharmacol 2021;12:691099.
74.    Baldassarro VA, Perut F, Cescatti M, Pinto V, Fazio N, Alastra G, et al. Intra-individual variability in the neuroprotective and promyelinating properties of conditioned culture medium obtained from human adipose mesenchymal stromal cells. Stem Cell Res Ther 2023;14:128. 
75.    Ding SLS, Kumar S, Ali Khan MS, Mok PL. Human mesenchymal stem cells expressing erythropoietin enhance survivability of retinal neurons against oxidative stress: an in vitro study. Front Cell Neurosci 2018;12:190.
76.    Froger N, Matonti F, Roubeix C, Forster V, Ivkovic I, Brunel N, et al. VEGF is an autocrine/paracrine neuroprotective factor for injured retinal ganglion neurons. Sci Rep 2020;10:12409.
77.    Pereiro X, Miltner AM, La Torre A, Vecino E. Effects of adult Müller cells and their conditioned media on the survival of stem cell-derived retinal ganglion cells. Cells 2020;9:1759.
78.    Peng ZQ, Guan XH, Yu ZP, Wu J, Han XH, Li MH, et al. Human amniotic mesenchymal stem cells-derived conditioned medium and exosomes alleviate oxidative stress-induced retinal degeneration by activating PI3K/Akt/FoxO3 pathway. Exp Eye Res 2024;244:109919. 
79.    Sugitani S, Tsuruma K, Ohno Y, Kuse Y, Yamauchi M, Egashira Y, et al. The potential neuroprotective effect of human adipose stem cells conditioned medium against light-induced retinal damage. Exp Eye Res 2013;116:254-264. 

Articles in Press, Accepted Manuscript
Available Online from 21 November 2026